ArticleJournal of clinical immunology2008

Treatment of multiple sclerosis with methylprednisolone and mitoxantrone modulates the expression of CXC chemokine receptors in PBMC.

Bartosz Bielecki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.